Related Experiment Video
Updated: Jan 15, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease
Natasha Venugopal1, Andrew McGowan1, Yoshitaka Inoue2,3,4
1Blood and Marrow Transplant Program, Division of Hematology and Oncology, Penn State Cancer Institute, 500 University Dr. Hershey, Hershey, PA, 17033, USA.
No abstract available in PubMed .
More Related Videos
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Cell-mediated Immune Responses
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure